Bridging excellent research and innovative product


Cherry Biotech is rooted in academics labs. Our first CherryTemp technology has been originally developped at the Institut Curie and the ENS Paris during CEO Jeremy Cramer’s PhD work.

We naturally follow on building tight relationships with academic labs as we know that basic science is the breeding ground of innovation. Our challenge is to transfer ideas into technologies and make them available for the scientific community. Our partners are precious advisors for our developments.


  • 15



  • 150



Cups of coffee
  • 499

    Cups of coffee


Organ on a chip

Human-on-a-chip to revolutionize diagnostic and drug development.

Artificial Intelligence

AI Technology to support decision making for e-health and drug-developpment

Smart Devices

Wearable IoT devices for live monitoring and e-health



GATEONE | Cell µBioreactor

Teesside University and Cherry Biotech have been selected to work on a miniaturized microbioreactor. This device will allow long-term culture and monitoring of liveing cells. In addition to constant perfusion and cell monitoring (pH, density…), this project aims at sensing metabolites in a user-friendly microbioreactor.

This project is a perfect example of Cherry’s focus at working in tightrelationship with end users on specific lab challenges.


CISTEM aims at developing a Heart-On-a-chip based on induced pluripotent Stem cell Technology for personalized Medicine. By promoting international staff exchange, CISTEM will provide a novel miniaturized platform for investigation of muscular rare diseases (Duchenne Muscular Dystrophy) able to address the burning issues in precision medicine today. CISTEM will bring together and synergistically several highly promising research directions which are too often investigated separately at the academic level but also at the industrial one.


IMAGINe will develop a device for long-term imaging of Organ-on-a-Chip applications. IMAGINe aims at creating a skin-on-a-chip model. This enabling technology controls the environment (e.g. temperature, fluid flow) of Organ-on-a-Chip cultures to keep these viable during imaging. The IMAGINe device uniquely enables the long-term monitoring of cellular processes in the Organ-on-a-Chip. This will be validated using a human skin-on-chip and a metastatic melanoma-on-chip model, in combination with novel cell-based therapeutics to inhibit metastasis.

This is a unique website which will require a more modern browser to work! Please upgrade today!